News & Views

Clinical practice guidelines

New Guidelines in Cancer Care

Guidelines give oncology nurses an evidence-based, standardized approach to cancer care. But guidelines are most effective used when they’re used as a regular part of practice—a process referred to as implementation.
With several oncology societies releasing new guidelines in 2020 and 2021, including ONS and the American Society of Clinical Oncology (ASCO), the implementation process requires nurse managers and leaders to facilitate staff education, maintain a high quality of care, and answer the all-important question: “Why are we doing this?”

Trending Topics

View All Topics

Protecting Nurses and Patients and Advancing Practice Drive ONS Advocacy

Protecting Nurses and Patients and Advancing Practice Drive ONS Advocacy

In Case You Missed It: Here Are the Big ONS Changes in Recent Years

In Case You Missed It: Here Are the Big ONS Changes in Recent Years

FDA Approves Isatuximab-Irfc for Multiple Myeloma

U.S. Food and Drug Administration (FDA)

FDA Approves Isatuximab-Irfc for Multiple Myeloma

Muscle Quality Predicts Efficacy of NSCLC Immunotherapy

Muscle Quality Predicts Efficacy of NSCLC Immunotherapy

Oncology Drug Reference Sheet: Decitabine and Cedazuridine

Cancer treatments

Oncology Drug Reference Sheet: Decitabine and Cedazuridine

FDA Approves Idecabtagene Vicleucel as the First Cell-Based Gene Therapy for Adult Patients With Multiple Myeloma

Clinical practice

FDA Approves Idecabtagene Vicleucel as the First Cell-Based Gene Therapy for Adult Patients With Multiple Myeloma

Zydus Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Acyclovir Sodium Injection

Clinical practice

Zydus Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Acyclovir Sodium Injection

Infection Prevention for Oncology Nurses

Clinical practice

Infection Prevention for Oncology Nurses

Research Validates Tools to Increase Screening in Communities of Color

Cancer research

Research Validates Tools to Increase Screening in Communities of Color

Diabetes May Increase Hematologic Cancer Risk and Mortality

Cancer risk factors

Diabetes May Increase Hematologic Cancer Risk and Mortality

All Patients, Regardless of Insurance, Must Have Access to Cancer Screening

Cancer screening

All Patients, Regardless of Insurance, Must Have Access to Cancer Screening

Genetic Disorder Reference Sheet: CHEK2 Gene Pathogenic Variants

Genetics & genomics

Genetic Disorder Reference Sheet: CHEK2 Gene Pathogenic Variants

FDA Approves Pembrolizumab for Esophageal or GEJ Carcinoma

U.S. Food and Drug Administration (FDA)

FDA Approves Pembrolizumab for Esophageal or GEJ Carcinoma

FDA Advises Healthcare Professionals Not to Use BD’s ChloraPrep™ 3 ml Applicators

U.S. Food and Drug Administration (FDA)

FDA Advises Healthcare Professionals Not to Use BD’s ChloraPrep™ 3 ml Applicators

Meet Your ONS Leader: Susie Maloney-Newton

Meet Your ONS Leader: Susie Maloney-Newton

Fear of Recurrence May Actually Contribute to Cancer Recurrence

Cancer recurrence

Fear of Recurrence May Actually Contribute to Cancer Recurrence

Don’t Get Trapped in the Pitfalls of Perfectionism

Nurse well-being

Don’t Get Trapped in the Pitfalls of Perfectionism

What the Evidence Says About Music Therapy for Cancer-Related Fatigue?

Symptom management

What the Evidence Says About Music Therapy for Cancer-Related Fatigue

Management Strategies for Cutaneous Toxicity From EGFR Inhibitors

Advanced Practice Nursing (APRN)

Management Strategies for Cutaneous Toxicity From EGFR Inhibitors

$FDA Approves Tivozanib for Relapsed or Refractory Advanced Renal Cell Carcinoma$

Oncology drug research

FDA Approves Tivozanib for Relapsed or Refractory Advanced Renal Cell Carcinoma

Lung Cancer Screening Guidelines to Reduce Disparities May Increase Them Instead—But Risk Model Can Help

Cancer screening

Lung Cancer Screening Guidelines to Reduce Disparities May Increase Them Instead—But Risk Model Can Help

Manage Adverse Events From PI3K Inhibitors for Breast Cancer

Manage Adverse Events From PI3K Inhibitors for Breast Cancer

$FDA Grants Accelerated Approval to Axicabtagene Ciloleucel for Relapsed or Refractory Follicular Lymphoma$

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Axicabtagene Ciloleucel for Relapsed or Refractory Follicular Lymphoma

Leadership Survey Identifies Areas for Chapter Support

Leadership Survey Identifies Areas for Chapter Support

Nurse Scientists Guide the Evidence in Symptom Science, and Inaugural Colloquium Recognizes That Impact on a National Level

Oncology nurse scientist

Nurse Scientists Guide the Evidence in Symptom Science, and Inaugural Colloquium Recognizes That Impact on a National Level

FDA Approves Lorlatinib for ALK-Positive Metastatic NSCLC

FDA Approves Lorlatinib for ALK-Positive Metastatic NSCLC

Nursing Considerations for Colorectal Cancer Survivorship Care

Survivorship care plans

Nursing Considerations for Colorectal Cancer Survivorship Care

U.S. Sees Another Record-Breaking Decrease in Cancer Deaths, but Disparities Remain

Cancer research

U.S. Sees Another Record-Breaking Decrease in Cancer Deaths, but Disparities Remain

Patient Education Reduces Barriers and Increases Adherence Rates

Patient Education

Patient Education Reduces Barriers and Increases Adherence Rates

$FDA Grants Accelerated Approval to Melphalan Flufenamide for Relapsed or Refractory Multiple Myeloma$

Clinical practice

FDA Grants Accelerated Approval to Melphalan Flufenamide for Relapsed or Refractory Multiple Myeloma

Invest in Hope for Nursing’s Future During Oncology Nursing Foundation’s 40th Anniversary

Invest in Hope for Nursing’s Future During Oncology Nursing Foundation’s 40th Anniversary

Self-Care Is Essential When Working Remotely

Nurse well-being

Self-Care Is Essential When Working Remotely

February 25, 2021

Medicaid Expansion Coincides With Earlier Colon Cancer Diagnosis Rates

Medicaid Expansion Coincides With Earlier Colon Cancer Diagnosis Rates

February 24, 2021

FDA Approves Cemiplimab-Rwlc for NSCLC With High PD-L1 Expression

Clinical practice

FDA Approves Cemiplimab-Rwlc for NSCLC With High PD-L1 Expression

February 23, 2021

Be Alert for Axillary Adenopathy After COVID-19 Vaccination

Be Alert for Axillary Adenopathy After COVID-19 Vaccination

February 19, 2021

CMS Changes to Medicare Prescription Coverage Could Affect Patient Care

Access to Cancer Care

CMS Changes to Medicare Prescription Coverage Could Affect Patient Care

February 18, 2021

Mortality Rates After Cancer Surgery Decrease, but Racial Disparities Remain

Mortality Rates After Cancer Surgery Decrease, but Racial Disparities Remain

February 17, 2021

COVID-19’s Implications for People With Cancer and Oncology Nurses

COVID-19’s Implications for People With Cancer and Oncology Nurses

February 16, 2021

FDA Approves Trilaciclib to Reduce Chemotherapy-Induced Myelosuppression

FDA Approves Trilaciclib to Reduce Chemotherapy-Induced Myelosuppression

February 15, 2021

Inclusion in National Repository Helps Move ONS Guidelines™ Evidence to Practice

Clinical practice guidelines

Inclusion in National Repository Helps Move ONS Guidelines™ Evidence to Practice

February 15, 2021

The Case of the Sensitive Staging System

Survivorship care plans

The Case of the Sensitive Staging System

February 15, 2021

ONS Past President Mary Gullatte, PhD, RN, ANP-BC, AOCN®, LSSYB, FAAN

ONS’s First African American President Shares Insights and Advice in Honor of Black History Month

February 15, 2021

How to Manage Survivor Guilt During a Pandemic

Patient Support

How to Manage Survivor Guilt During a Pandemic

February 11, 2021

FDA Approves Cemiplimab-Rwlc for Locally Advanced and Metastatic Basal Cell Carcinoma

U.S. Food and Drug Administration (FDA)

FDA Approves Cemiplimab-Rwlc for Locally Advanced and Metastatic Basal Cell Carcinoma

February 10, 2021

Targeted Radiation Reduces Pain From Spine Metastasis

Targeted Radiation Reduces Pain From Spine Metastasis

February 10, 2021

$FDA Approves Lisocabtagene Maraleucel for Relapsed or Refractory Large B-Cell Lymphoma$

U.S. Food and Drug Administration (FDA)

FDA Approves Lisocabtagene Maraleucel for Relapsed or Refractory Large B-Cell Lymphoma

February 10, 2021

How Can Oncology Nurses Reduce Isolation for Caregivers?

How Can Oncology Nurses Reduce Isolation for Caregivers?

February 09, 2021

Pandemics Have Serious Psychological Implications for Nurses

Nurse well-being

Pandemics Have Serious Psychological Implications for Nurses

February 09, 2021

FDA Grants Accelerated Approval to Umbralisib for Marginal Zone and Follicular Lymphoma

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Umbralisib for Marginal Zone and Follicular Lymphoma

February 08, 2021

Back to Top ▲